27/09/2023 Ionis Pharmaceuticals and Roche enter new partnership for two novel programmes for Alzheimer's and Huntington's diseases Science watch
26/09/2023 Synaptogenix reports new findings from its Phase II trial of Bryostatin-1 in AD Science watch
21/09/2023 Alzheimer’s Disease Data Initiative announces its inaugural cohort of William H. Gates Sr. Fellows Science watch
21/09/2023 Findings from the A4 Study of solanezumab for preclinical AD have been published Science watch
18/09/2023 RECOGNISED convenes all project partners for its annual General Assembly meeting Science watch
14/09/2023 Anavex reports follow-on analysis data from its Phase IIb/III study of blarcamesine in early AD Science watch
13/09/2023 Alzheon reports positive findings from its Phase II trial of ALZ-801 for early AD Science watch
12/09/2023 Study suggests that sedentary behaviour could be a potential risk factor for incident dementia Science watch
11/09/2023 People with FTD from different ethnic backgrounds exhibit varying symptoms, according to a new study in JAMA Neurology Science watch
03/08/2023 Alector provides an update on its INVOKE-2 and INFRONT-3 clinical trials of treatments for early Alzheimer’s disease and frontotemporal dementia Science watch
